Open an evidence report for a gene and a disorder pair and get the whole picture in one place — curated evidence, clinical features, variants, mechanisms, drugs, trials, and the literature — with every claim linked back to its source.
the complete body of evidence linking one gene to one disorder, assembled and cited on a single, fully traceable page.
the missing intersection: one gene × one disorder, gone deep, with the evidence separated by type and linked back to its origin.
"One pair. One page. Every kind of evidence, and every claim traceable to its source."
Origin: geno- (Greek génos, gene) + -pathy (Greek -patheia, disease).
To validate whether your gene and your disorder are really connected, you move between gene summaries, disease databases, OMIM and Orphanet, HPO phenotypes, ClinVar, the GWAS Catalog, pathway and regulatory resources, drug databases, ClinicalTrials.gov, and PubMed.
Then you have to work out which facts actually apply to your exact pair, reconcile the aliases and identifiers, tell curated evidence from inference, and make sure a drug trial in some unrelated indication isn't fooling you into seeing disease-specific evidence.
Genopathy does that assembly for you — once, per pair.
A cited synthesis and headline counts — sources, variants, symptoms, compounds, trials, publications — plus status badges.
A deterministic, fully cited narrative, plus a clinical-actionability panel when that evidence exists.
Each contributing source named, with accessions, deep links, an evidence-strength label, and what it implies.
An AI-generated gene summary (labeled as such) alongside the source summaries it was distilled from.
Disorder summary, prevalence, aliases, identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen) and curated outbound resources.
Canonical HPO features grouped by body system, with frequency and penetrance — de-duplicated so counts aren't inflated.
ClinVar variants with disorder-specific significance, review stars, HGVS, consequence and origin distributions.
Gene-associated phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect-size ranges.
GeneHancer regulatory elements for the pair, with coordinates, score, element type, elite status and supporting PubMed.
HPO concepts annotated to both gene and disorder, and biological pathways they share, with supporting literature.
Gene-targeting drugs and associated compounds with class, approval status, mechanism, indications, trials and structures.
Trials reached through the pair's compounds — disorder-targeting trials kept separate from other-indication ones.
Publications linked to the pair with full metadata, plus one deduplicated, numbered reference register for the whole page.
Each report adapts to the evidence available for that pair. The knowledge base it draws on profiles at scale:
Updated periodically as GeneCards & MalaCards are updated.
A cryopyrin-associated autoinflammatory disorder — manually curated, with disorder-targeting therapeutic annotation.
Open report →A laminopathy driving premature aging — a worked example of variant, mechanism, and literature evidence in one place.
Open report →Whether you're evaluating for a lab, a biotech, or a clinical-research group, we'll get you set up with access and a walkthrough on the pairs that matter to your work.
Full access to the evidence-report library across 80,000+ gene–disorder pairs.
A guided walkthrough tailored to the genes and disorders you study.
A direct line to our team for questions, feedback, and new-pair requests.
Your request has been received. The Genopathy partnerships team will follow up by email.